Tsuji Petra A, Walle Thomas
Department of Cell and Molecular Pharmacology and Experimental Therapeutics Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.
Chem Biol Interact. 2007 Aug 15;169(1):25-31. doi: 10.1016/j.cbi.2007.05.001. Epub 2007 May 18.
Polycyclic aromatic hydrocarbons (PAH) such as benzo[a]pyrene (BaP) mainly induce lung cancer in humans, but induce liver cancer in fishes. The chemoprevention of cancers through inhibition of molecular events via phytochemicals is a potentially beneficial area of research, and has been carried out in human cell cultures in the past. Carcinogenesis initiation events are thought to occur in similar ways in fish and humans. Our study investigated the feasibility of using cultured rainbow trout CRL-2301 liver cells as a model for BaP-induced carcinogenesis and its prevention by dietary phytochemicals. Treatment with 1 microM BaP resulted in extensive time-dependent covalent binding to cellular DNA and marked cytochrome P450 (CYP) 1A induction, for both about a 20-fold increase, which is similar to what has been observed in cultured human cells. A surprisingly high expression of epoxide hydrolase (EH) activity in these cells likely contributed substantially to the bioactivation of BaP. Two methoxylated flavones and the stilbene resveratrol were effective inhibitors of both the BaP-DNA binding and CYP 1A induction, in particular 5,7-dimethoxyflavone (5,7-DMF), supporting a role for these dietary compounds as cancer chemopreventive agents. Unlike in human liver or bronchial cells, the main mechanism of inhibition of BaP-induced CYP 1A activity in trout liver cells appears to be direct competition at the protein level. Different cellular responses in any particular model used can be expected and the effect of cell context on the biological responses to xenobiotics, including carcinogens as well as polyphenols, must be considered. The trout CRL-2301 cells' sensitivity to BaP treatment is a clear advantage when contemplating a model system for studies of PAH-induced carcinogenesis and cancer chemoprevention. However, extrapolation to human organs should be done cautiously.
多环芳烃(PAH)如苯并[a]芘(BaP)主要诱发人类肺癌,但诱发鱼类肝癌。通过植物化学物质抑制分子事件来进行癌症化学预防是一个具有潜在益处的研究领域,过去已在人类细胞培养中开展。癌症发生起始事件在鱼类和人类中被认为以相似方式发生。我们的研究调查了使用培养的虹鳟鱼CRL - 2301肝细胞作为BaP诱导致癌及其通过膳食植物化学物质预防的模型的可行性。用1微摩尔BaP处理导致与细胞DNA的广泛时间依赖性共价结合以及显著的细胞色素P450(CYP)1A诱导,两者均增加约20倍,这与在培养的人类细胞中观察到的情况相似。这些细胞中环氧水解酶(EH)活性的惊人高表达可能在很大程度上促成了BaP的生物活化。两种甲氧基黄酮和芪类白藜芦醇是BaP - DNA结合和CYP 1A诱导的有效抑制剂,特别是5,7 - 二甲氧基黄酮(5,7 - DMF),支持这些膳食化合物作为癌症化学预防剂的作用。与人类肝细胞或支气管细胞不同,在鳟鱼肝细胞中抑制BaP诱导的CYP 1A活性的主要机制似乎是在蛋白质水平的直接竞争。在任何特定使用的模型中都可能预期有不同的细胞反应,并且必须考虑细胞背景对包括致癌物以及多酚在内的异源生物(包括致癌物)生物反应的影响。当考虑用于PAH诱导致癌和癌症化学预防研究的模型系统时,鳟鱼CRL - 2301细胞对BaP处理的敏感性是一个明显优势。然而,向人类器官的外推应谨慎进行。